Padsevonil (UCB 0942) is an orally administered small molecule compound, being developed by UCB Biopharma, for the treatment of drug refractory epilepsy and partial-onset seizures in patients with drug refractory epilepsy. Reference standards of Padsevonil API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Padsevonil - API Standards [catalogue_number] => PA 16 2790000 [category_ids] => ,78,75,70,76,82, [chemical_name] => [weight] => 432.79 [form] => C14H14ClF5N4O2S [cas] => 1294000-61-5 [pslug] => 1294000-61-5-padsevonil-api-pa162790000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 16 2790000
CAS :
Molecular Formula : C14H14ClF5N4O2S
Molecular Weight : 432.79
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....